Kobayashi Pharmaceutical Company Limited announced earnings results for the year ended March 31, 2016. For the year, the company reported net income attributable to owners of the parent company of JPY 13.47 billion, or JPY 331.11 per share, compared to JPY 12.45 billion, or JPY 305.46 per share, for the year ended March 31, 2015. Net sales were JPY 137.21 billion compared to JPY 128.34 billion for the year ended March 31, 2015. Operating income was JPY 18.26 billion compared to JPY 17.92 billion for the year ended March 31, 2015.

For the year ending December 31, 2016, the company expects net income attributable to owners of the parent company to be JPY 13.5 billion, or JPY 168.05 per share. For the year ending December 31, 2016, the company expects net sales to be JPY 117.3 billion.